[HTML][HTML] Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry
MD Wood, KL Murkitt, M Ho, JM Watson… - British journal of …, 1999 - ncbi.nlm.nih.gov
MD Wood, KL Murkitt, M Ho, JM Watson, F Brown, AJ Hunter, DN Middlemiss
British journal of pharmacology, 1999•ncbi.nlm.nih.govFunctional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2,
hM3, hM4 and hM5 using microphysiometry - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search
PMC Full-Text Archive Search in PMC Advanced Search User Guide Journal List Br J
Pharmacol v.126(7); 1999 Apr PMC1565933 Other Formats PDF (125K) Actions Cite Collections
Share Permalink Copy RESOURCES Similar articles Cited by other articles Links to NCBI …
hM3, hM4 and hM5 using microphysiometry - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search
PMC Full-Text Archive Search in PMC Advanced Search User Guide Journal List Br J
Pharmacol v.126(7); 1999 Apr PMC1565933 Other Formats PDF (125K) Actions Cite Collections
Share Permalink Copy RESOURCES Similar articles Cited by other articles Links to NCBI …
Abstract
1. This study describes the pharmacological comparison of the muscarinic partial agonists sabcomeline, xanomeline and milameline at human cloned muscarinic receptor subtypes (hM 1–5).
ncbi.nlm.nih.gov